Raounak Drugs Private Limited

Raounak Drugs Private Limited - pharma in Indore, Madhya Pradesh, India. FY 2026 financials & compliance.
CIN U33111MP2014PTC032643 Incorporated 31 March 2014 ROC Gwalior HQ Indore, Madhya Pradesh, India
Active Private Limited Company pharma MSME · Micro
Revenue · FY 2019
₹25,880
Latest filing
Net profit · FY 2019
₹25,880
Net margin 100%
EBITDA · FY 2019
₹25,880
EBITDA margin 100%
Authorised capital
₹1.3 Cr
Registered with MCA
Paid-up capital
₹1.3 Cr
Issued & subscribed
Open charges
₹5.32 Cr
Secured borrowings
Company age
12 yrs
Est. 2014
Directors on board
6
As per MCA filings

About Raounak Drugs Private Limited

Data last updated:

Raounak Drugs Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 March 2014 and has been in existence for over 12 years.

The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U33111MP2014PTC032643. Its GSTIN is 23AAGCR9025B1ZQ (Madhya Pradesh).

The company has an authorised share capital of ₹1.3 Cr and a paid-up capital of ₹1.3 Cr. It is led by directors including Rajesh Kumar Sharma (Managing Director) and Sanjeev Tiwari (Whole-Time Director).

Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at Office No. 102 01st Floor Harshdeep Avenue 157 Chikitsak Nagar Satya Sai, Indore, Madhya Pradesh, India – 452010.

As per the financials filed for FY 2019, the company reported a revenue of ₹25,880. For the same year it recorded a net profit of ₹25,880 (net margin 100%) and EBITDA of ₹25,880 (EBITDA margin 100%).

The company is associated with 1 brand: Ronak Health Care. As per MCA filings, the company has open charges of ₹5.32 Cr on record. Court records list 3 cases involving the company, including 1 filed by the company and 2 filed against it; 2 cases are pending.

Raounak Drugs Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-44-0005786). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U33111MP2014PTC032643
Registration Number 032643
Incorporation Date 31 March 2014
ROC Gwalior
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MP-44-0005786
Key People
Rajesh Kumar Sharma Managing Director Sanjeev Tiwari Whole-Time Director Aniruddha Deharia Director

Recognitions & Rankings of Raounak Drugs

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-MP-44-0005786

Contact details

Raounak Drugs Private Limited's registered office is in Indore, Madhya Pradesh. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Office No. 102 01st Floor Harshdeep Avenue 157 Chikitsak Nagar Satya Sai, Indore, Madhya Pradesh, India – 452010
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Raounak Drugs Private Limited, buy the company report.

Comprehensive company report
Raounak Drugs Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Raounak Drugs operates one associated brand: Ronak Health Care. Each brand links to its own profile.

BrandDescriptionWebsite
Ronak Health Care
Manufactures and distributes pharmaceuticals, cosmetics, herbal products, and wellness items worldwide.ronakhealthcare.in

Financials of Raounak Drugs Private Limited

FY 2019 filings available

Raounak Drugs Private Limited reported revenue of ₹25,880 for FY 2019.

Revenue · FY 2019
₹25,880
Net profit · FY 2019
₹25,880 margin 100%
EBITDA · FY 2019
₹25,880 margin 100%

Financial Statement Summary

MetricsFY 2018-19FY 2017-18FY 2016-17FY 2015-16FY 2014-15
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹25,880
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹25,880
Profit Before Tax
Tax Expense
Net Profit (PAT)₹25,880
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2018-19FY 2017-18FY 2016-17FY 2015-16FY 2014-15
Profitability
EBITDA Margin100%
Net Profit Margin100%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Raounak Drugs Private Limited, buy the company report.

Board of directors of Raounak Drugs Private Limited

Raounak Drugs has 6 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Aniruddha DehariaDirector21 Mar 20224 Years 7 MonthsCurrent
Tulasiram DehariyaDirector21 Mar 20224 Years 7 MonthsCurrent
Sanjeev TiwariWhole-Time Director31 Mar 201412 Years 7 MonthsCurrent
Alok LashkariAdditional Director03 Dec 20196 Years 11 MonthsCurrent
Rajesh Kumar SharmaManaging Director09 Jan 201610 Years 10 MonthsCurrent
Shraddha TiwariDirector23 May 201511 Years 5 MonthsCurrent
View all directors

Peer comparison

Raounak Drugs Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Silicon Scientific Private Limited₹27,285 (FY 2024)Bangalore, Karnataka, India
Dupha Formulations (India) Private Limited₹27,000 (FY 2019)Ujjain, Madhya Pradesh, India
Lyotex Lifesciences Private Limited₹26,940 (FY 2024)Thane, Maharashtra, India
Innovera Pharmaceuticals Private Limited₹26,861 (FY 2025)-5.0%Hyderabad, Telangana, India
Proheal Formulations Private Limited₹26,828 (FY 2025)315.0%Chandigarh, India
Raounak Drugs Private Limitedthis company₹25,880 (FY 2019)₹25,880100%Indore, Madhya Pradesh, India
Panera Biotec Private Limited₹25,820 (FY 2024)-100.0%New Delhi, Delhi, India
Save Earth Labs Private Limited₹25,200 (FY 2025)Delhi, India
Emdon Pharmacy Private Limited₹25,065 (FY 2023)Cuttack, Odisha, India
Gopish Pharma Limited₹25,000 (FY 2025)-26.0%Delhi, India
Liventis Pharmceuticals Private Limited₹24,713 (FY 2024)-80.0%Palwal, Haryana, India

To see the full peer comparison of Raounak Drugs Private Limited, buy the company report.

Auditor

Raounak Drugs Private Limited is audited by NEERAJ MISHRA & CO for the financial year 2019.

Auditor firmFinancial yearFirm registration number
NEERAJ MISHRA & COFY 2019021724C

Shareholding

The shareholding of Raounak Drugs Private Limited is on record for 5 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2019FY 2018FY 2017FY 2016FY 2015
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Raounak Drugs Private Limited, buy the company report.

Charges & borrowings

Open charges
₹5.32 Cr
Satisfied charges
None
Breakdown by lending institutions
Others₹5.32 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
17 Jan 2025101083883Others₹51.77 LakhOpen
29 Oct 2021100521153Others₹80 LakhOpen
21 Aug 2017100118993Others₹4 CrOpen

Total charge records: 3 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Raounak Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Raounak Drugs has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
23AAGCR9025B1ZQMadhya PradeshActive01 Jul 2017

To see the full GST registrations and return filing status of Raounak Drugs Private Limited, buy the company report.

Recent activity

Raounak Drugs Private Limited has 10 board changes on record since 2014: 6 appointments and 4 cessations. The latest: Aniruddha Deharia was appointed as Director on 21 Mar 2022.

Charges
A charge with Others amounted to Rs. 0.52 Cr with Charge ID 101083883 was registered on 17 Jan 2025.
Appointed
Aniruddha Deharia was appointed as Director.
Appointed
Tulasiram Dehariya was appointed as Director.
Charges
A charge with Others amounted to Rs. 0.80 Cr with Charge ID 100521153 was registered on 29 Oct 2021.
Appointed
Alok Lashkari was appointed as Additional Director.
AGM
Raounak Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records.
Filing
Raounak Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Gwalior.
Charges
A charge with Others amounted to Rs. 4.00 Cr with Charge ID 100118993 was registered on 21 Aug 2017.
Ceased
Rajesh Kumar Sharma ceased to be Additional Director.
Ceased
Sanjeev Tiwari ceased to be Director.
Appointed
Rajesh Kumar Sharma was appointed as Managing Director.
Ceased
Gangadhar Chandrashekar Uppin ceased to be Director.

4 earlier events are in the company report.

Frequently asked questions

Raounak Drugs is an active private limited company based in Indore, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 31 March 2014 (12+ years old) and is registered under CIN U33111MP2014PTC032643.

Raounak Drugs has 6 current directors:

The latest financial statements of Raounak Drugs on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from 2015 are in the company report.

The GSTIN of Raounak Drugs is 23AAGCR9025B1ZQ, registered in Madhya Pradesh.

The CIN (Corporate Identification Number) of Raounak Drugs is U33111MP2014PTC032643. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Raounak Drugs has 3 court cases on record: 1 filed by the company and 2 filed against it. 2 are pending. Most are in the district courts.

Raounak Drugs was incorporated on 31 March 2014, making it 12+ years old. It is registered with the Registrar of Companies, Gwalior.

The peers of Raounak Drugs by revenue are Silicon Scientific Private Limited, Dupha Formulations (India) Private Limited, Lyotex Lifesciences Private Limited, Innovera Pharmaceuticals Private Limited, Proheal Formulations Private Limited and 5 more, all in the Pharma industry (Formulations).

Aniruddha Deharia was appointed as Director on 21 Mar 2022. Tulasiram Dehariya was appointed as Director on 21 Mar 2022. Alok Lashkari was appointed as Additional Director on 03 Dec 2019. Raounak Drugs has 10 board changes on record in total.

Yes, Raounak Drugs is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-44-0005786).

The registered office of Raounak Drugs is at Office No. 102 01st Floor Harshdeep Avenue 157 Chikitsak Nagar Satya Sai, Indore, Madhya Pradesh, India – 452010.